ANGIODYNAMICS INC — Director's Dealing 2022

Feb 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2022-02-03

Reporting Person: Trowbridge Stephen A (EVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-03	Common Stock	F	583	$20.48	Disposed	75498	Direct

Footnotes

F1: The exempt disposition of 583 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on February 3, 2020.